497 related articles for article (PubMed ID: 14576199)
1. Mechanisms of hepatocyte growth factor-mediated vascular smooth muscle cell migration.
Ma H; Calderon TM; Kessel T; Ashton AW; Berman JW
Circ Res; 2003 Nov; 93(11):1066-73. PubMed ID: 14576199
[TBL] [Abstract][Full Text] [Related]
2. [FAK antisense oligodeoxynucleotides inhibit vascular smooth muscle cell migration and adhesion mediated by FAK-ERK1/2 signaling pathway].
Yin H; Wang LH; Huo Y; Peng X; Xia CF; Tang CS
Yao Xue Xue Bao; 2002 May; 37(5):334-8. PubMed ID: 12579835
[TBL] [Abstract][Full Text] [Related]
3. Adhesion, actin cytoskeleton organisation and the spreading of colon adenocarcinoma cells induced by EGF are mediated by alpha2beta1 integrin low clustering through focal adhesion kinase.
Pichard V; Honoré S; Kovacic H; Li C; Prevôt C; Briand C; Rognoni JB
Histochem Cell Biol; 2001 Oct; 116(4):337-48. PubMed ID: 11702192
[TBL] [Abstract][Full Text] [Related]
4. [Focal adhesion kinase and mitogen activated protein kinase are involved in vascular smooth muscle cells migration and proliferation stimulated by fibronectin].
Yin H; Wang L; Huo Y; Peng X; Xia C; Tang C
Zhonghua Yi Xue Za Zhi; 2002 May; 82(9):622-5. PubMed ID: 12133485
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of focal adhesion kinase expression or activity disrupts epidermal growth factor-stimulated signaling promoting the migration of invasive human carcinoma cells.
Hauck CR; Sieg DJ; Hsia DA; Loftus JC; Gaarde WA; Monia BP; Schlaepfer DD
Cancer Res; 2001 Oct; 61(19):7079-90. PubMed ID: 11585739
[TBL] [Abstract][Full Text] [Related]
6. Activated focal adhesion kinase involved in adhesion and migration of vascular smooth muscle cells stimulated by fibronectin.
Yin H; Wang L; Huo Y; Peng X; Xia C; Tang C
Chin Med J (Engl); 2002 Apr; 115(4):494-7. PubMed ID: 12133282
[TBL] [Abstract][Full Text] [Related]
7. Targeting of alpha(v) integrins interferes with FAK activation and smooth muscle cell migration and invasion.
Varadarajulu J; Laser M; Hupp M; Wu R; Hauck CR
Biochem Biophys Res Commun; 2005 Jun; 331(2):404-12. PubMed ID: 15850774
[TBL] [Abstract][Full Text] [Related]
8. Pyk2 and FAK regulate neurite outgrowth induced by growth factors and integrins.
Ivankovic-Dikic I; Grönroos E; Blaukat A; Barth BU; Dikic I
Nat Cell Biol; 2000 Sep; 2(9):574-81. PubMed ID: 10980697
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of hepatocyte growth factor-induced retinal endothelial cell migration and growth.
Cai W; Rook SL; Jiang ZY; Takahara N; Aiello LP
Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1885-93. PubMed ID: 10845613
[TBL] [Abstract][Full Text] [Related]
10. Reactive oxygen species mediate Endothelin-1-induced activation of ERK1/2, PKB, and Pyk2 signaling, as well as protein synthesis, in vascular smooth muscle cells.
Daou GB; Srivastava AK
Free Radic Biol Med; 2004 Jul; 37(2):208-15. PubMed ID: 15203192
[TBL] [Abstract][Full Text] [Related]
11. Control of smooth muscle cell proliferation and phenotype by integrin signaling through focal adhesion kinase.
Morla AO; Mogford JE
Biochem Biophys Res Commun; 2000 May; 272(1):298-302. PubMed ID: 10872843
[TBL] [Abstract][Full Text] [Related]
12. Phosphatidylinositol-3-kinase activation mediates proline-rich tyrosine kinase 2 phosphorylation and recruitment to beta1-integrins in human CD34+ cells.
Melikova S; Dylla SJ; Verfaillie CM
Exp Hematol; 2004 Nov; 32(11):1051-6. PubMed ID: 15539082
[TBL] [Abstract][Full Text] [Related]
13. Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation.
Augé N; Maupas-Schwalm F; Elbaz M; Thiers JC; Waysbort A; Itohara S; Krell HW; Salvayre R; Nègre-Salvayre A
Circulation; 2004 Aug; 110(5):571-8. PubMed ID: 15277330
[TBL] [Abstract][Full Text] [Related]
14. Hepatocyte growth factor induction of collagenase 3 production in human osteoarthritic cartilage: involvement of the stress-activated protein kinase/c-Jun N-terminal kinase pathway and a sensitive p38 mitogen-activated protein kinase inhibitor cascade.
Reboul P; Pelletier JP; Tardif G; Benderdour M; Ranger P; Bottaro DP; Martel-Pelletier J
Arthritis Rheum; 2001 Jan; 44(1):73-84. PubMed ID: 11212179
[TBL] [Abstract][Full Text] [Related]
15. HGF/NK4, a four-kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice.
Kuba K; Matsumoto K; Date K; Shimura H; Tanaka M; Nakamura T
Cancer Res; 2000 Dec; 60(23):6737-43. PubMed ID: 11118060
[TBL] [Abstract][Full Text] [Related]
16. Differential regulation of ERK1/2 and p38(MAPK) by components of the Rho signaling pathway during sphingosine-1-phosphate-induced smooth muscle cell migration.
Galaria II; Fegley AJ; Nicholl SM; Roztocil E; Davies MG
J Surg Res; 2004 Dec; 122(2):173-9. PubMed ID: 15555614
[TBL] [Abstract][Full Text] [Related]
17. Different modes and qualities of tyrosine phosphorylation of Fak and Pyk2 during epithelial-mesenchymal transdifferentiation and cell migration: analysis of specific phosphorylation events using site-directed antibodies.
Nakamura K; Yano H; Schaefer E; Sabe H
Oncogene; 2001 May; 20(21):2626-35. PubMed ID: 11420674
[TBL] [Abstract][Full Text] [Related]
18. Growth factors stimulate kidney proximal tubule cell migration independent of augmented tyrosine phosphorylation of focal adhesion kinase.
Cao Y; Baig MR; Hamm LL; Wu K; Simon EE
Biochem Biophys Res Commun; 2005 Mar; 328(2):560-6. PubMed ID: 15694384
[TBL] [Abstract][Full Text] [Related]
19. Hepatocyte growth factor induces proliferation of lens epithelial cells through activation of ERK1/2 and JNK/SAPK.
Choi J; Park SY; Joo CK
Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2696-704. PubMed ID: 15277494
[TBL] [Abstract][Full Text] [Related]
20. Src and Cas are essentially but differentially involved in angiotensin II-stimulated migration of vascular smooth muscle cells via extracellular signal-regulated kinase 1/2 and c-Jun NH2-terminal kinase activation.
Kyaw M; Yoshizumi M; Tsuchiya K; Kagami S; Izawa Y; Fujita Y; Ali N; Kanematsu Y; Toida K; Ishimura K; Tamaki T
Mol Pharmacol; 2004 Apr; 65(4):832-41. PubMed ID: 15044612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
